Does natalizumab therapy worsen neuromyelitis optica?
The Walton Centre NHS Foundation Trust, Liverpool, UK. anu.jacob@thewaltoncentre.nhs.uk
Anu
A
Jacob
Michael
M
Hutchinson
Liene
L
Elsone
Siobhan
S
Kelly
Rehiana
R
Ali
Ivars
I
Saukans
Niall
N
Tubridy
Mike
M
Boggild
D000293:Adolescent; D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use; D001921:Brain / Q000473:pathology*; D018450:Disease Progression; D005260:Female; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000473:pathology; D000069442:Natalizumab; D009413:Nerve Fibers, Myelinated / Q000473:pathology*; D009471:Neuromyelitis Optica / Q000209:etiology* / Q000473:pathology
D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab